Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723603 · ClinicalTrials.gov registry record · NA
An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds
A NA study, sponsored by Medline Industries.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03723603 is a NA study that was terminated before completion, run by Medline Industries. The registered enrollment target is 8 participants.
The verdict
NCT03723603, a NA study, was terminated before completion, sponsored by Medline Industries.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with an appropriate moisture retentive secondary dressing. Patients will visit the clinic twice a week to have the powder re-applied. Wound evaluations will take place once a week at the outpatient clinic, with the intervention lasting up to twelve weeks. Concurrent standard of care, such as compression for venous ulcers, will be provided.
Interventions
- DEVICE Fibrillar collagen powder dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-11-09 |
| Est. Completion | 2019-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03723603
The ClinicalTrials.gov registry entry for NCT03723603 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medline Industries, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fibrillar collagen powder dressing is the first listed.
NCT03723603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03723603 about?
NCT03723603 is a clinical study titled "An Evaluation of a Collagen Dressing to Treat Chronic, Stalled Lower-extremity Wounds". Patients who meet the inclusion criteria will be provided with fibrillar collagen powder dressing. The powder dressing will be used in accordance with its label. After cleansing the wound by the clinical site staff, the powder is placed directly on the wound, and then the wound will be covered with ...
What is the current status of trial NCT03723603?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2018-11-09. Estimated completion is 2019-07-30.
What interventions are being tested in trial NCT03723603?
The interventions under investigation include: Fibrillar collagen powder dressing (DEVICE).
Who is sponsoring clinical trial NCT03723603?
This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.